Notable Guests
AM
Abraham Morgentaler, MD
1x
AM
Adanma Ayanambakkam, MD
1x
AM
Alan Bryce, MD
1x
AM
Amy Pearlman, MD
1x
DK
Daniel S. Kellner
1x
EM
Elizabeth Nally, MBBS
1x
EJ
Elliot Justin
1x
GC
Gabe Canales
1x
GM
Gabriela Diaz, MD
1x
HA
Hans Arora
1x
JH
Jason Hafron
1x
JM
Jessica Yih, MD
1x
JM
Joshua Halpern, MD, MS
1x
JM
Joshua Lang, MD, MS
1x
KT
Kari Tikkinen
1x
Recent Episodes
✨
Cribriform histology is an important adverse feature in prostate cancer.
✨
POISE-3 trial evaluated tranexamic acid in urologic surgery.
Kari Tikkinen
Expert APProach: Advancing APP Leadership & Expertise in Urology, With Susanne Quallich, PhD, ANP-BC
✨
APP leadership and specialization in urology discussed.
Susanne Quallich
✨
Advances in advanced prostate cancer care highlighted.
✨
N-of-1 trial shows varied tamsulosin responses.
✨
Improving communication and teamwork in the OR.
Hans Arora
✨
HoLEP adoption strategies and patient selection.
Daniel S. Kellner
✨
Dr. Flannigan presented phase 2 data for ST-01, a lidocaine solution for chronic scrotal pain.
Ryan Flannigan, MD
✨
Dr. Nima Almassi discusses long-term data for bladder preservation in muscle-invasive bladder cancer.
Nima Almassi, MD
✨
Sasha Vereecken explains how urodynamics advanced reconstructive urology.
Sasha Vereecken, BScN, RN
✨
Drs. Amy Pearlman and Andrew Cohen discuss managing patient expectations.
Amy Pearlman, MD
✨
Dr. Narmina Khanmammadova presents interim findings on pelvic floor therapy before HoLEP.
Narmina Khanmammadova, MD
✨
Dr. Jessica Yih reviews evidence for testosterone therapy in women.
Jessica Yih, MD
✨
Dr. Nally discusses decision regret and toxicity perception in RCC patients.
Elizabeth Nally, MBBS
✨
BCG maintenance therapy's importance in NMIBC is discussed.
✨
History of the belief that testosterone drives prostate cancer explored.
Abraham Morgentaler, MD
✨
Wearable technology's potential in sexual health is explored.
Elliot Justin
✨
Key phase 3 advances in prostate cancer practice changes highlighted.
Alan Bryce, MD
✨
Rising incidence of young-onset bladder cancer is examined.
Gabriela Diaz, MD
Laura Bukavina, MD
✨
Integrating emerging molecular biomarkers into clinical practice discussed.
Joshua Lang, MD, MS